IL7 and breast cancer: Research conducted using a mouse BC model has demonstrated elevated levels of interleukin-2 (IL-2) and interleukin-7 (IL-7), along with cytotoxic T cells and dendritic cells exhibiting antitumour activity, subsequent to the elimination of CAFs.